< Back to companies

Voiceitt’s speech recognition technology, unlike standard speech recognition systems developed and distributed by the world’s major technology industry players, is designed to recognize non-standard speech patterns of people with mild to very severe speech disabilities. Supported by a combination of over $11,500,000 in government grants, corporate cash prizes, and traditional investment, the Israel-based startup developed and validated its first commercial product, a mobile application that translates unintelligible speech in real time, enabling people with severe speech impairments to communicate by voice. Tested in 2018 in four languages, five countries and over 200 users via its institutional partners, the Voiceitt app enabled by the company's proprietary speech technology enables spontaneous verbal interaction previously inaccessible to many of these individuals, who instead relied on bulky and expensive assistive communication devices - and in some cases, chose not to communicate at all. The company's goal is to validate and productize its AI-driven tech in two use cases: a mobile application enabling human to human spontaneous communication; and secondly, integration of the technology in a smart home context, enabling accessibility of voice-driven technologies to people with motor, cognitive and speech-related challenges, thus enabling independence, autonomy, inclusion, and quality of life for these individuals. Microsoft’s M12 and the Amazon Alexa Fund recently announced equity investment in Voiceitt. Voiceitt's mission is to make speech recognition technologies and products truly accessible to everyone, regardless of physical limitations or motor disabilities.

Share
Shareable draft
Get Involved in Voiceitt

Company Info

Founded
2015
Website
www.voiceitt.com/

Categories

RehabilitationDigital Health ServicesAI / MLAccess to Care

Disease Areas

Technologies

Speech RecognitionMobile ApplicationsAI/Machine LearningAssistive Technology
Only accessible to MedStartr community members. Join now

What do you think of Voiceitt?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Your scores and comments are shown with your review on this company's profile.

Get Involved in Voiceitt
💬

Hi, I'm Syggy!

MedStartr's AI healthcare innovation superhero. Just click me for whatever you need! 🥰

💬
Hi, I'm Syggy
your healthcare innovation buddy
💬

Ask Syggy anything

What MedStartr is, how it can help you, events, joining...

You're chatting as a visitor: this conversation stays in this browser, isn't linked to any account, and doesn't move over if you join. Join free